Avalo Therapeutics(DE:C6K0)
€7.49+0.04 (+0.54%)
DE:C6K0
Avalo Therapeutics earnings date
€7.49
At close:+0.04 (+0.54%)
Avalo Therapeutics (C6K0) Q2 2021 Earnings Report
0 Followers
DE:C6K0 Q2 2021 EPS Results
- Actual EPS
- -EUR 470.27
- Consensus EPS
- -EUR 435.43
- Beat/Miss
- Missed by -EUR 34.83
- One Year Ago EPS
- -EUR 470.27
DE:C6K0 Q2 2021 Revenue Results
- Actual Revenue
- EUR 3.04M
- Expected Revenue
- EUR 302.08K
- Beat/Miss
- Beat by +EUR 2.74M
- YoY Revenue Growth
- +150.79%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/02/2021
- Time
- After Close
- Conference Call
- Monday, August 2, 2021
DE:C6K0 Upcoming Earnings
Avalo Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C6K0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -0.41- | -0.68 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.53-0.31 | -1.99 | 84.47% (+1.68) | |
| Aug 06, 2026 | 2026 (Q2) | -0.53-0.75 | -1.74 | 56.77% (+0.99) | |
| May 13, 2026 | 2026 (Q1) | -0.93-0.89 | -1.13 | 21.60% (+0.24) | |
| Mar 23, 2026 | 2025 (Q4) | -1.32-0.68 | -2.09 | 67.39% (+1.41) | |
| Nov 06, 2025 | 2025 (Q3) | -1.50-1.99 | -2.57 | 22.61% (+0.58) | |
| Aug 07, 2025 | 2025 (Q2) | -1.27-1.74 | -12.76 | 86.35% (+11.02) | |
| May 12, 2025 | 2025 (Q1) | -1.21-1.13 | -127.91 | 99.11% (+126.77) | |
| Mar 20, 2025 | 2024 (Q4) | -0.15-2.09 | -9.16 | 77.23% (+7.08) | |
| Nov 07, 2024 | 2024 (Q3) | -1.08-2.57 | -23.95 | 89.28% (+21.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
